MARATTO

article · Therapeutic Advances in Vaccines and Immunotherapy

Exploring COVID-19 vaccine adverse events among pregnant women: a cross-sectional study, 2022

20242 citationsOpen accessZagazig University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The COVID-19 vaccine significantly reduces post-vaccination COVID-19. Although COVID-19 vaccine-related AES are prevalent, analgesics and antipyretics effectively treat most of them.

Research topics

  • COVID-19 Impact on Reproduction
  • Vaccine Coverage and Hesitancy
  • Pregnancy and Medication Impact

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/25151355241285594

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.